C12N 2310/51
In polymeric form
Official title: in polymeric form, e.g. multimers, concatemers
C12N2310/51 (In polymeric form) appears on 241 US grants and 465 published applications in this corpus.
Search patents in C12N- Granted patents
- 241
- Published applications
- 465
- Assignees
- 219
- Inventors
- 849
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 6 |
| 2006 | 0 | 4 |
| 2007 | 1 | 2 |
| 2008 | 0 | 8 |
| 2009 | 2 | 13 |
| 2010 | 3 | 18 |
| 2011 | 8 | 24 |
| 2012 | 7 | 20 |
| 2013 | 15 | 16 |
| 2014 | 14 | 13 |
| 2015 | 12 | 27 |
| 2016 | 17 | 25 |
| 2017 | 21 | 22 |
| 2018 | 21 | 30 |
| 2019 | 14 | 28 |
| 2020 | 17 | 26 |
| 2021 | 13 | 27 |
| 2022 | 20 | 39 |
| 2023 | 11 | 37 |
| 2024 | 17 | 36 |
| 2025 | 17 | 27 |
| 2026 | 11 | 14 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Endosomal cleavable linkers15 Sep 2026US 12,735,702 B2Alnylam Pharmaceuticals, Inc.
- RNA molecules, methods of producing circular RNA, and treatment methods15 Sep 2026US 12,737,877 B2Cornell University
- Hairpin-like oligonucleotide-conjugated spherical nucleic acid11 Aug 2026US 12,702,719 B2Northwestern University
- Multimeric oligonucleotides with divided strands5 May 2026US 12,618,071 B2Mpeg La, LLC
- Compositions for herpesvirus transcriptional feedback circuit disruption and uses thereof21 Apr 2026US 12,606,829 B2The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Gladstone
- Compositions and methods related to multiparatopic aptamers16 Jul 2026US 2026/0201391 A1North Carolina State University
- Hepatic Delivery Platforms For Multimeric RNAi Agent Conjugates and Methods of Use Thereof25 Jun 2026US 2026/0176631 A1Arrowhead Pharmaceuticals, Inc.
- Inverted chimeric sirna molecules and methods of use thereof4 Jun 2026US 2026/0152746 A1The University of North Carolina at Chapel Hill
- Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use23 Apr 2026US 2026/0109728 A1Tallac Therapeutics, Inc.
- Multivalent trident aptamers for molecular recognition, methods of making and uses thereof9 Apr 2026US 2026/0098270 A1McMaster University
Most cited
By later US patents
- RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)108US 7,176,304 B22007
- Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression95US 8,349,809 B2Dicerna Pharmaceuticals, Inc. · 2013
- Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products88US 11,162,102 B2Dna Twopointo Inc. · 2021
- Polyamides for nucleic acid delivery71US 8,685,368 B22014
- Methods and compositions for the specific inhibition of gene expression by double-stranded RNA68US 8,084,599 B2City of Hope · 2011